SE7708192L - Sett att framstella androstan-17-on-derivat - Google Patents

Sett att framstella androstan-17-on-derivat

Info

Publication number
SE7708192L
SE7708192L SE7708192A SE7708192A SE7708192L SE 7708192 L SE7708192 L SE 7708192L SE 7708192 A SE7708192 A SE 7708192A SE 7708192 A SE7708192 A SE 7708192A SE 7708192 L SE7708192 L SE 7708192L
Authority
SE
Sweden
Prior art keywords
derivatives
androstan
produce
way
sterol
Prior art date
Application number
SE7708192A
Other languages
English (en)
Other versions
SE440779B (sv
Inventor
A Weber
M Kennecke
H Dahl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7708192L publication Critical patent/SE7708192L/sv
Publication of SE440779B publication Critical patent/SE440779B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/005Degradation of the lateral chains at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/863Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7708192A 1976-07-16 1977-07-14 Sett att framstella androstan-17-on-derivat SE440779B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (2)

Publication Number Publication Date
SE7708192L true SE7708192L (sv) 1978-01-17
SE440779B SE440779B (sv) 1985-08-19

Family

ID=5983514

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7708192A SE440779B (sv) 1976-07-16 1977-07-14 Sett att framstella androstan-17-on-derivat

Country Status (18)

Country Link
US (1) US4179336A (sv)
JP (1) JPS5315493A (sv)
AT (1) AT363196B (sv)
BE (1) BE856860A (sv)
CH (3) CH627190A5 (sv)
CS (1) CS200517B2 (sv)
DD (4) DD132439A5 (sv)
DE (1) DE2632677A1 (sv)
DK (1) DK142372C (sv)
FR (4) FR2365588A1 (sv)
GB (1) GB1585786A (sv)
HU (4) HU182789B (sv)
IE (1) IE45304B1 (sv)
IT (1) IT1077339B (sv)
NL (1) NL7706638A (sv)
SE (1) SE440779B (sv)
SU (1) SU980628A3 (sv)
YU (1) YU164277A (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
DE69621281T2 (de) * 1995-02-28 2002-12-05 Nippon Shokubai Co., Ltd. Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
ES2725808T3 (es) * 2003-05-23 2019-09-27 Nektar Therapeutics Derivados de PEG que contienen dos cadenas de PEG
CN102656153B (zh) * 2009-10-29 2015-02-18 延世大学校产学协力团 新型血管渗漏阻断剂
WO2012116290A2 (en) 2011-02-25 2012-08-30 Washington University Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
CA3152410A1 (en) 2011-10-14 2013-04-18 Sage Therapeutics, Inc. 3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof for the treatment of cns related disorders
TR201808616T4 (tr) 2012-12-18 2018-07-23 Sage Therapeutics Inc Nöroaktif 19-alkoksi-17-ikameli steroidler, bunların ön ilaçları ve bunları kullanan tedavi yöntemleri.
WO2014127201A1 (en) * 2013-02-15 2014-08-21 Washington University Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for gaba type-a receptors
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
RU2019126333A (ru) 2013-04-17 2019-10-08 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
CN113527400B (zh) 2013-04-17 2024-06-28 萨奇治疗股份有限公司 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
WO2015010054A2 (en) 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2014308621C1 (en) 2013-08-23 2022-01-06 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SMT202000414T1 (it) 2014-10-16 2020-09-10 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
MX2021004492A (es) 2014-10-16 2022-12-05 Sage Therapeutics Inc Composiciones para el tratamiento de trastornos del snc.
ME03749B (me) 2014-11-27 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
CA3030420C (en) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
CN114206900A (zh) 2019-05-31 2022-03-18 萨奇治疗股份有限公司 神经活性类固醇及其组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (sv) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
US3738983A (en) * 1971-08-06 1973-06-12 Searle & Co Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone
DE2534911C2 (de) * 1975-08-01 1985-04-18 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Also Published As

Publication number Publication date
HU179344B (en) 1982-10-28
DE2632677C2 (sv) 1988-06-16
ATA504677A (de) 1980-12-15
FR2372175A1 (fr) 1978-06-23
US4179336A (en) 1979-12-18
FR2365588B1 (sv) 1982-06-25
DK323677A (da) 1978-01-17
IE45304L (en) 1978-01-16
DK142372B (da) 1980-10-20
GB1585786A (en) 1981-03-11
YU164277A (en) 1982-08-31
IE45304B1 (en) 1982-07-28
BE856860A (fr) 1978-01-16
DD136141A5 (de) 1979-06-20
CH627190A5 (sv) 1981-12-31
HU182789B (en) 1984-03-28
DD136142A5 (de) 1979-06-20
CS200517B2 (en) 1980-09-15
JPS5315493A (en) 1978-02-13
CH629222A5 (de) 1982-04-15
AT363196B (de) 1981-07-10
DK142372C (da) 1981-03-23
JPS6117477B2 (sv) 1986-05-07
DD137235A5 (de) 1979-08-22
DE2632677A1 (de) 1978-01-26
SU980628A3 (ru) 1982-12-07
FR2372174A1 (fr) 1978-06-23
HU182790B (en) 1984-03-28
SE440779B (sv) 1985-08-19
CH629503A5 (de) 1982-04-30
FR2365588A1 (fr) 1978-04-21
NL7706638A (nl) 1978-01-18
FR2372176A1 (fr) 1978-06-23
IT1077339B (it) 1985-05-04
HU182681B (en) 1984-02-28
DD132439A5 (de) 1978-09-27

Similar Documents

Publication Publication Date Title
IE45304L (en) Androstan-17-one derivatives.
ES477387A1 (es) Procedimiento para preparar derivados de guanidina.
AU554294B2 (en) Beta-lactam antibiotics
IE46169L (en) Thiazolidine, thiazine and morpholine carboxylic acids and¹esters
ES459412A1 (es) Un metodo de preparacion de compuestos heterociclicos deri- vados de hidantoina.
GB2007663A (en) Sulphonylated omega - amidinophenyl- alpha -aminocarhoxylic acid amides
GB1476720A (en) Substituted cyclohexanes
AU576199B2 (en) Beta-carboline derivatives
ES474543A1 (es) Procedimiento para producir derivados del acido propionico.
AU5035085A (en) Antiallergic 5-alkyl-1-phenyl-2-piperazinoalkyl-pyrazoline- 3-one compounds
ATE23188T1 (de) Mn-superoxyddismutase, ihre herstellung und ihre verwendung.
ES433680A1 (es) Procedimiento para la preparacion de derivados de arilpipe-razinicos de la adenina.
ES462012A1 (es) Un procedimiento para preparar derivados de cefalosporinas.
ES459644A1 (es) Un procedimiento para la produccion de un compuesto oxigena-do.
SE7705213L (sv) Antikonceptionellt medel
SE7608575L (sv) Sett att framstella 5-androsten-17-on-derivat
ES459755A1 (es) Procedimiento para preparar carbamatos de oximas de deriva- dos del acido isonitrosocianocetico.
FI844644A0 (fi) Framstaellningsfoerfarande foer indanylderivat och deras anvaendning.
KR890004994A (ko) 신규 백금 착화합물
ES457096A1 (es) Procedimiento de preparacion de la n-propargil-piperonilami-na.
GR74870B (sv)
GB2003866A (en) Thiourea derivatives
GB1534242A (en) Derivatives of 2-imino-4-thiazolines and thiazolidines
SE8104195L (sv) Sett att framstella 3-keto-cyklopenten-5-oxi-derivat
SE7704033L (sv) Oxotiaforeningar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7708192-5

Effective date: 19930204

Format of ref document f/p: F